micro News and Research

RSS

MiR-34a plays a key role in obesity

Scientists have identified a key molecular player in a chain of events in the body that can lead to fatty liver disease, Type II diabetes and other metabolic abnormalities associated with obesity. By blocking this molecule, the researchers were able to reverse some of the pathology it caused in obese mice.

21 Sep 2012

Rainbow Biosciences explores NASA technology to produce adult stem cells for medical research

Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp., announced today that it is exploring the possible use of micro-gravity technology developed by NASA to produce three-dimensional adult stem cells for medical research purposes.

19 Sep 2012

Dynamic optical projection stereolithography can rapidly fabricate microscale 3D structures

Nanoengineers at the University of California, San Diego have developed a novel technology that can fabricate, in mere seconds, microscale three dimensional (3D) structures out of soft, biocompatible hydrogels.

14 Sep 2012

Urban air pollution exposure during pregnancy may lead to lower vitamin D levels in offspring

Gestational exposure to ambient urban air pollution, especially during late pregnancy, may contribute to lower vitamin D levels in offspring, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM).

14 Sep 2012

WHO says Nigeria not on track to turn back polio despite having tools, capacity

"The World Health Organization (WHO) on Tuesday said Nigeria was not on track in the effort to eradicate wild polio virus before the end of December this year," Leadership/AllAfrica.com reports.

13 Sep 2012

AB SCIEX launches Eksigent ekspert nanoLC 400 system

AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the Eksigent ekspert nanoLC 400 system.

10 Sep 2012

Strong antiviral antibody response observed in oral administration of Flucide

NanoViricides, Inc. announced today that anti-influenza drug candidates under its FluCide program, when given orally, led to strong antiviral antibody response. The antibody response with Oral administration was stronger than that with IV administration and was substantially greater than that observed with oseltamivir.

5 Sep 2012

Fusion-negative prostate tumours display more aberrant DNA methylations

In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until now.

5 Sep 2012

Ultrastable RNA nanoparticles may help treat cancer and viral infections

A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue.

4 Sep 2012

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

The primitive stem cell state we created is called an “induced pluripotent stem cell” (iPSC). iPSC are a new, unique, and artificially-created type of stem cell that were first described in 2006 by a Japanese scientist named Shinya Yamanaka.

4 Sep 2012

Whole-genome sequencing can track origin and movement of TB pathogens

Reconstructing the spread of killer diseases such as tuberculosis (TB) from person to person using DNA sequencing quickly identifies the origin and movement of pathogens. This approach is directly informing public health strategies to control infectious disease outbreaks, says a scientist speaking at the Society for General Microbiology's Autumn Conference at the University of Warwick.

4 Sep 2012

Digested coconut oil able to attack the bacteria that cause tooth decay

Digested coconut oil is able to attack the bacteria that cause tooth decay. It is a natural antibiotic that could be incorporated into commercial dental care products, say scientists presenting their work at the Society for General Microbiology's Autumn Conference at the University of Warwick.

3 Sep 2012

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Norman H. Lee, Ph.D., professor of pharmacology at the George Washington University School of Medicine and Health Sciences (SMHS), received a total of $405,001 in grant funding from the National Institute on Drug Abuse (NIDA) to continue to study the correlation between genetics and susceptibility to drug abuse.

30 Aug 2012

Blockade Medical's Barricade Coil System successfully treats patients with aneurysms

Blockade Medical announced today the first patients have been treated with the Barricade Coil System. Patients treated with the Barricade Coil System presented with diverse cerebral aneurysms.

27 Aug 2012

Proteonomix enters license agreement for new anti-tumor technology

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.

23 Aug 2012

Portable Micro-Plasma Device may help repair skin after laser surgery

A National Cheng Kung University (NCKU) research team has designed a Portable Micro-Plasma Device (PMPD) that may be the ultimate solution to repairing the skin after laser surgery.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

Mercury exposure hypertension concerns ‘unfounded’

Mercury exposure is not associated with an increased risk for hypertension, US research shows.

13 Aug 2012

New class of polymers resistant to bacterial attachment

Using state-of-the-art technology scientists at The University of Nottingham have discovered a new class of polymers that are resistant to bacterial attachment. These new materials could lead to a significant reduction in hospital infections and medical device failures.

13 Aug 2012

Scientists discover new class of polymers that are resistant to bacterial attachment

13 Aug 2012

micro News and Research

MiR-34a plays a key role in obesity

Rainbow Biosciences explores NASA technology to produce adult stem cells for medical research

Dynamic optical projection stereolithography can rapidly fabricate microscale 3D structures

Urban air pollution exposure during pregnancy may lead to lower vitamin D levels in offspring

WHO says Nigeria not on track to turn back polio despite having tools, capacity

AB SCIEX launches Eksigent ekspert nanoLC 400 system

Strong antiviral antibody response observed in oral administration of Flucide

Fusion-negative prostate tumours display more aberrant DNA methylations

Ultrastable RNA nanoparticles may help treat cancer and viral infections

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

Whole-genome sequencing can track origin and movement of TB pathogens

Digested coconut oil able to attack the bacteria that cause tooth decay

GWSMHS professor to study correlation between genetics and susceptibility to drug abuse

Blockade Medical's Barricade Coil System successfully treats patients with aneurysms

Proteonomix enters license agreement for new anti-tumor technology

Portable Micro-Plasma Device may help repair skin after laser surgery

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Mercury exposure hypertension concerns ‘unfounded’

New class of polymers resistant to bacterial attachment

Scientists discover new class of polymers that are resistant to bacterial attachment

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News